Medicare Enrolled
Dr. Marc Makhani, M.D.
Internal Medicine · Los Angeles, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Makhani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Makhani?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Makhani
Dr. Marc Makhani is an internal medicine specialist in Los Angeles, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Makhani performed 19,515 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Makhani received a total of $85,291 from 58 pharmaceutical and/or device companies across 701 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Makhani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 1% volume in CA
$85,291 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗19,515
Medicare services
Top 1% in CA for internal medicine
Not available
Unique patients (not deduplicated)
$85
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
5,075 | $102 | $900 |
| Prolonged inpatient or observation care, each additional 15 minutes This code is used for prolonged hospital inpatient or observation care services that extend beyond the total time required for the primary evaluation and management service. It covers each additional 15-minute increment of time spent by the provider. |
4,407 | $26 | $150 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,684 | $110 | $400 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
1,605 | $153 | $500 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
1,464 | $67 | $500 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
1,113 | $68 | $800 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
1,113 | $28 | $150 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
980 | $110 | $302 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
709 | $149 | $1,000 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
381 | $181 | $1,000 |
| New patient office visit, complex (60-74 min) | 236 | $184 | $601 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
207 | $68 | $1,850 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
90 | $129 | $2,600 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
68 | $213 | $2,700 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
68 | $80 | $200 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
53 | $85 | $1,800 |
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
45 | $0 | $18 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
39 | $128 | $2,500 |
| Online digital E/M service, established patient, 21+ minutes An online digital evaluation and management service for an established patient. This service requires a total time of 21 or more minutes over a period of up to 7 days. |
28 | $40 | $138 |
| Endoscopic control of upper GI bleeding A flexible endoscope is used to locate and stop bleeding in the esophagus, stomach, or upper small intestine. |
26 | $161 | $2,400 |
| Emergency department visit, high complexity An emergency department visit involving a high level of medical decision making. |
25 | $147 | $1,000 |
| Endoscopic insertion of feeding tube A flexible tube is placed into the esophagus, stomach, or upper small intestine using an endoscope to allow for feeding or medication administration. |
20 | $100 | $1,100 |
| Endoscopic removal of esophagus, stomach, or small bowel polyps This procedure uses an endoscope and a mechanical snare to remove polyps or growths from the esophagus, stomach, or upper small bowel. |
20 | $114 | $2,150 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
18 | $175 | $1,600 |
| Endoscopic insertion of stomach tube A flexible endoscope is used to guide the placement of a tube into the stomach. |
15 | $169 | $2,000 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
13 | $68 | $1,141 |
| Injection, fentanyl citrate, 0.1 mg | 13 | $1 | $31 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$85,291
Total received (2018-2024)
Avg $12,184/year across 7 years
Top 2% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
701
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,996
2023
$9,347
2022
$50,519
2021
$11,557
2020
$1,254
2019
$3,599
2018
$6,019
Payments by company (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$764
Nevro Corp.
$291
Ardelyx, Inc.
$284
QOL Medical, LLC
$279
ABBVIE INC.
$256
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$151
PFIZER INC.
$136
GENZYME CORPORATION
$82
Edwards Lifesciences Corporation
$77
Alnylam Pharmaceuticals Inc.
$67
IRONWOOD PHARMACEUTICALS, INC
$58
Celgene Corporation
$54
Merck Sharp & Dohme LLC
$47
AIMMUNE THERAPEUTICS, INC.
$46
Bayer Healthcare Pharmaceuticals Inc.
$44
Boehringer Ingelheim Pharmaceuticals, Inc.
$43
Janssen Biotech, Inc.
$42
Phathom Pharmaceuticals, Inc.
$39
HEARTFLOW, INC.
$39
Amgen Inc.
$36
Gilead Sciences, Inc.
$31
Kiniksa Pharmaceuticals International, plc
$29
Regeneron Healthcare Solutions, Inc.
$27
Intercept Pharmaceuticals, Inc.
$25
Exact Sciences Corporation
$20
Takeda Pharmaceuticals U.S.A., Inc.
$17
Itamar Medical Inc
$14
Top 3 companies account for 44.7% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$62,956
Allergan Inc.
$7,284
AbbVie Inc.
$3,986
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$3,572
QOL Medical, LLC
$936
ABBVIE INC.
$479
Ardelyx, Inc.
$444
AbbVie, Inc.
$389
Daiichi Sankyo Inc.
$348
Ironwood Pharmaceuticals, Inc
$333
Amarin Pharma Inc.
$314
Celgene Corporation
$305
Nevro Corp.
$291
Janssen Biotech, Inc.
$270
Takeda Pharmaceuticals U.S.A., Inc.
$237
PFIZER INC.
$212
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$207
Merck Sharp & Dohme Corporation
$192
GENZYME CORPORATION
$191
Regeneron Healthcare Solutions, Inc.
$132
Dova Pharmaceuticals
$131
NESTLE HEALTHCARE NUTRITION INC.
$131
Nestle HealthCare Nutrition Inc.
$130
Synergy Pharmaceuticals Inc
$126
IRONWOOD PHARMACEUTICALS, INC
$125
Janssen Pharmaceuticals, Inc
$123
Edwards Lifesciences Corporation
$113
Ferring Pharmaceuticals Inc.
$98
Romark Laboratories, LC
$92
Gilead Sciences, Inc.
$92
RedHill Biopharma Inc.
$83
Alfasigma USA, Inc.
$79
AIMMUNE THERAPEUTICS, INC.
$72
Novartis Pharmaceuticals Corporation
$69
Alnylam Pharmaceuticals Inc.
$67
Merck Sharp & Dohme LLC
$67
Bayer Healthcare Pharmaceuticals Inc.
$65
Boehringer Ingelheim Pharmaceuticals, Inc.
$63
Lilly USA, LLC
$51
Eisai Inc.
$43
Phathom Pharmaceuticals, Inc.
$39
HEARTFLOW, INC.
$39
Shionogi Inc
$30
Kiniksa Pharmaceuticals International, plc
$29
Medtronic, Inc.
$26
Intercept Pharmaceuticals, Inc.
$25
Biohaven Pharmaceutical Holding Company Ltd.
$24
Abbott Laboratories
$24
Bausch Health US, LLC
$21
ARBOR PHARMACEUTICALS, INC.
$21
Exact Sciences Corporation
$20
SANOFI-AVENTIS U.S. LLC
$19
DEXCOM, INC.
$18
Sandoz Inc.
$15
Itamar Medical Inc
$14
Biohaven Pharmaceuticals, Inc.
$12
EISAI INC.
$12
Napo Pharmaceuticals Inc
$8
Top 3 companies account for 87.0% of all-time payments
Associated products mentioned in payments ›
AMJEVITA · AMVUTTRA · APLENZIN · APRISO · AVSOLA · Alinia · Alinia Tablets 500mg 30 count bottle · Arcalyst · CLENPIQ · CREON · Cologuard Collection Kit · Corlanor · Creon · DEXCOM G6 TRANSMITTER · DIFICID · DUPIXENT · Dayvigo · Doptelet · EMGALITY · ENTRESTO · Edarbi · Epclusa · FFRct · GATTEX · HUMIRA · HYRIMOZ · Humira · IBSRELA · ICDs · INFLECTRA · INJECTAFER · JANUVIA · JARDIANCE · Kerendia · LINZESS · LifeVest · Linzess · MOTEGRITY · MOUNJARO · Mavyret · Motegrity · Movantik · Mulpleta · Mytesi · NURTEC ODT · OCALIVA · PLENVU · PRALUENT · RELISTOR · RINVOQ · Repatha · SAPIEN 3 Ultra RESILIA · SKYRIZI · STELARA · SUCRAID · Senza · Sucraid · TREMFYA · TRINTELLIX · TRULANCE · TRULICITY · TYRX · Talicia · Trulance · VIBERZI · VOQUEZNA · VOWST · VYNDAQEL · Vascepa · WatchPATONE · XARELTO · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
4,889
County median income
$87,760
Nearest hospital to ZIP centroid (approximate)
CEDARS-SINAI MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Makhani is a clinical cardiology specialist, with above-average Medicare volume (top 1% in CA), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Makhani experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Makhani performed 5,075 hospital follow-up visit, high complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Makhani receive payments from pharmaceutical companies?
Yes. Dr. Makhani received a total of $85,291 from 58 companies across 701 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Makhani's costs compare to other internal medicine physicians in Los Angeles?
Dr. Makhani's average Medicare payment per service is $85. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Makhani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Los Angeles
Browse internal medicine physicians in Los Angeles ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Allergan Inc. Payments to Doctors
See all physicians who received payments from Allergan Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology